A logo sits above windows at Novartis AG's headquarters in Basel, Switzerland, on Tuesday, July, 16, 2013. Novartis raised its profit and sales forecasts as generic competition for the Diovan blood-pressure medicine failed to materialize in the U.S. Photographer: Gianluca Colla/Bloomberg via Getty Images
